Spots Global Cancer Trial Database for docetaxel and epirubicin plus endostatin
Every month we try and update this database with for docetaxel and epirubicin plus endostatin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Trial of Neoadjuvant Endostar, Docetaxel and Epirubicin for Patients With Breast Cancer | NCT01479036 | Breast Cancer | docetaxel and e... docetaxel and e... | 18 Years - 70 Years | Xijing Hospital | |
Neoadjuvant Endostatin and Chemotherapy for Breast Cancer | NCT00604435 | Breast Cancer | docetaxel and e... docetaxel and e... | 18 Years - 70 Years | Xijing Hospital | |
Neoadjuvant Endostatin and Chemotherapy for Breast Cancer | NCT00604435 | Breast Cancer | docetaxel and e... docetaxel and e... | 18 Years - 70 Years | Xijing Hospital | |
Trial of Neoadjuvant Endostar, Docetaxel and Epirubicin for Patients With Breast Cancer | NCT01479036 | Breast Cancer | docetaxel and e... docetaxel and e... | 18 Years - 70 Years | Xijing Hospital |